Medical News Hubb
Advertisement
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
Medical News Hubb
No Result
View All Result
Home Pharmaceutical

GOP lawmakers seek answers about defunct NIH oversight committee

admin by admin
July 24, 2022
in Pharmaceutical



WASHINGTON — A trio of congressional Republicans wants to know why a committee tasked with oversight of the National Institutes of Health hasn’t met since 2015.

In a letter sent Thursday, the lawmakers pressed NIH leadership for answers about the mysterious disappearance of the Scientific Management Review Board, a committee that Congress empaneled in 2006 to ensure the agency was operating efficiently.

The scrutiny follows a recent STAT report about the committee disbanding, and broader questions about the agency’s future following the 2021 departure of longtime director Francis Collins.

advertisement

“According to a STAT review of agency records, the SMRB, tasked with making the NIH more efficient and more effective, ‘mysteriously stopped meeting seven years ago’ and SMRB members do not know why,” the letter states.

The letter was signed by three top Republicans on the powerful House Energy and Commerce Committee: Reps. Cathy McMorris Rodgers (Wa.), Morgan Griffith (Va.), and Brett Guthrie (Ky.). If the GOP regains a majority in the House in November’s midterm elections, McMorris Rodgers would likely become chair of the committee.

advertisement

While the NIH committee met regularly in its first years of existence, it stopped meeting in 2015, sparking at least one member to accuse Collins of resisting feedback.

Related:

The panel was supposed to improve efficiency at the NIH. It hasn’t even met for 7 years

“There wasn’t any notification that we weren’t going to meet again — it was just that the meetings stopped getting called,” Nancy Andrews, a onetime board member and the former dean of the Duke University School of Medicine, told STAT in May.

She added: “I had the sense that we were asking questions in areas that they didn’t really want to get into, and I suppose Francis in particular didn’t really want us working on.”





Source link

Previous Post

5 burning questions about Amazon’s $3.9 billion acquisition of One Medical

Next Post

AI shows potential to reduce sepsis deaths in real-world studies

Next Post

AI shows potential to reduce sepsis deaths in real-world studies

Recommended

Biden Recovering After Another Positive COVID Test

August 1, 2022

Endoscopic Balloon Dilation Effective for Small Bowel Strictures

July 24, 2022

Don't miss it

Medicines & Healthy Lifestyle

Astaxanthin: The Super Antioxidant That Comes From the Ocean

August 19, 2022
Pharmaceutical

Health Bulletin 19/August/2022

August 19, 2022
Medicines & Healthy Lifestyle

Fezolinetant NDA Accepted for Vasomotor Symptoms With Menopause

August 19, 2022
Medicines & Healthy Lifestyle

Think You Avoided Omicron? Think Again. Here’s Why You May Have Been Infected

August 19, 2022
News

COVID Healthcare; Hypertension Risk; and Opioid Therapy

August 19, 2022
Pharmaceutical

Investing in health workers can help close the vaccination gap

August 19, 2022

© 2022 Medical News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy.

Navigate Site

  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

Newsletter Sign Up

No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

© 2022 Medical News Hubb All rights reserved.